Investigation of the Ringer Perfusion Balloon Catheter
Completed · Not applicable · NCT04849169
Conditions: Coronary Artery Perforation
At a glance
- Research payments reported, 2025
- $11,830
- U.S. investigators named
- 3
- Sites paid
- 3
- Planned or actual enrollment
- 30
About the trial
- Sponsor
- Vascular Solutions LLC
- Tested
- Experimental (device)
- Dates
- Started 2022-07-18; completion 2023-11-21
- Results posted
- Not yet
The objective of this study is to demonstrate reasonable assurance that the Ringer catheter can be safely used to manage hemorrhage due to coronary vessel perforations while facilitating distal perfusion under the conditions of use prescribed in the labeling.
From ClinicalTrials.gov, last updated 2023-12-22. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Teleflex LLC reported $11,830 in research payments for this study in 2025 (5 payments).
Products named: Teleflex
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Farouc A. Jaffer, MD PHD Interventional Cardiology · Boston, MA
- Mohammad A. Alqarqaz, MD Cardiology · Detroit, MI
- Kathleen E. Kearney, M.D Interventional Cardiology · Seattle, WA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.